{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:52:22Z","timestamp":1770353542272,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A randomized, controlled, double-masked clinical trial was conducted with a combination antiviral-antimediator treatment for experimental rhinovirus colds. In all, 150 healthy men and women (aged 18\u201351 years) were randomly assigned to 1 of 3 groups: intranasal interferon (IFN)\u2013\u03b12b (6\u00d7106 U every 12 h \u00d7 3) plus oral chlorpheniramine (12 mg extended release) and ibuprofen (400 mg) every 12 h for 4.5 days (n=59 subjects); intranasal placebo plus oral chlorpheniramine and ibuprofen (n=61 subjects); or intranasal and oral placebos (n=30 subjects). Treatment was started 24 h after intranasal viral challenge. During the 4.5 days of treatment with IFN-\u03b12b, chlorpheniramine, and ibuprofen, the daily mean total symptom score was reduced by 33%\u201373%, compared with placebo. Treatment reduced the severity of rhinorrhea, sneezing, nasal obstruction, sore throat, cough, and headache and reduced nasal mucus production, nasal tissue use, and virus concentrations in nasal secretions. IFN-\u03b12b added to the effectiveness of chlorpheniramine and ibuprofen and was well tolerated<\/jats:p>","DOI":"10.1086\/341455","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T17:28:29Z","timestamp":1033406909000},"page":"147-154","source":"Crossref","is-referenced-by-count":57,"title":["Combined Antiviral-Antimediator Treatment for the Common Cold"],"prefix":"10.1093","volume":"186","author":[{"suffix":"Jr.","given":"Jack M.","family":"Gwaltney","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Winther","sequence":"first","affiliation":[{"name":"Otolaryngology\u2013Head and Neck Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Patrie","sequence":"first","affiliation":[{"name":"Health Evaluation Sciences, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Owen","family":"Hendley","sequence":"first","affiliation":[{"name":"Pediatrics, University of Virginia School of Medicine, Charlottesville"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,7,15]]},"reference":[{"key":"2020051022381585600_ref1","first-page":"1025","article-title":"Rhinovirus","volume-title":"Clinical virology","author":"Gwaltney","year":"1997"},{"key":"2020051022381585600_ref2","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1001\/jama.1993.03500170088039","article-title":"Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991","volume":"269","author":"Smith","year":"1993","journal-title":"JAMA"},{"key":"2020051022381585600_ref3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/AAC.23.5.671","article-title":"Therapeutic activity of enviroxime against rhinovirus infection in volunteers","volume":"23","author":"Phillpotts","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051022381585600_ref4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/infdis\/150.2.174","article-title":"Intranasal interferon-\u03b12 treatment of experimental rhinoviral colds","volume":"150","author":"Hayden","year":"1984","journal-title":"J Infect Dis"},{"key":"2020051022381585600_ref5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/jama.281.19.1797","article-title":"Efficacy of tremacamra, a soluble adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"2020051022381585600_ref6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/infdis\/166.4.776","article-title":"Combined antiviral and antimediator treatment of rhinovirus colds","volume":"166","author":"Gwaltney","year":"1992","journal-title":"J Infect Dis"},{"key":"2020051022381585600_ref7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/154.3.443","article-title":"Prevention of experimental coronavirus colds with intranasal \u03b1-2b interferon","volume":"154","author":"Turner","year":"1986","journal-title":"J Infect Dis"},{"key":"2020051022381585600_ref8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/jir.1989.9.285","article-title":"Comparative susceptibility of respiratory viruses to recombinant interferons-\u03b12b and -\u03b2","volume":"9","author":"Sperber","year":"1989","journal-title":"J Interferon Res"},{"key":"2020051022381585600_ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0166-3542(90)90061-B","article-title":"The efficacy of intranasal interferon\u03b1-2a in respiratory syncytial virus infection in volunteers","volume":"14","author":"Higgins","year":"1990","journal-title":"Antiviral Res"},{"key":"2020051022381585600_ref10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00006454-198803000-00033","article-title":"A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge","volume":"7","author":"Doyle","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"2020051022381585600_ref11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/clinids\/22.4.656","article-title":"Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds","volume":"22","author":"Gwaltney","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020051022381585600_ref12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1086\/515546","article-title":"Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold","volume":"25","author":"Turner","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2020051022381585600_ref13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/516105","article-title":"Efficacy of brompheniramine maleate treatment for rhinovirus colds","volume":"25","author":"Gwaltney","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2020051022381585600_ref14","first-page":"617","article-title":"Analgesic-antipyretin and antiinflammatory agents and drugs employed in the treatment of gout","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"Insel","year":"1996","edition":"9th ed"},{"key":"2020051022381585600_ref15","first-page":"817","article-title":"How effective are treatments other than antibiotics for acute sore throat","volume":"50","author":"Thomas","year":"2000","journal-title":"Br J Gen Pract"},{"key":"2020051022381585600_ref16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-117-1-37","article-title":"Effects of naproxen on experimental rhinovirus colds: a randomized, double-blind, controlled trial","volume":"117","author":"Sperber","year":"1992","journal-title":"Ann Intern Med"},{"key":"2020051022381585600_ref17","first-page":"670","article-title":"Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study","volume":"19","author":"Fogari","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"2020051022381585600_ref18","first-page":"161","article-title":"The effect of sulindac on the abnormal cough reflex associated with dry cough","volume":"255","author":"Nozhat","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"2020051022381585600_ref19","first-page":"709","article-title":"Rhinovirus","volume-title":"Laboratory diagnosis of viral Infection","author":"Couch","year":"1992","edition":"2d ed"},{"key":"2020051022381585600_ref20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archinte.1958.00260140099015","article-title":"Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity","volume":"101","author":"Jackson","year":"1958","journal-title":"Arch Intern Med"},{"key":"2020051022381585600_ref21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang K-Y","year":"1986","journal-title":"Biometrika"},{"key":"2020051022381585600_ref22","first-page":"59","article-title":"Regression analysis of count data","volume-title":"Econometric Society Monographs, no 30","author":"Cameron","year":"1998"},{"key":"2020051022381585600_ref23","first-page":"145","article-title":"Evaluation of an alpha agonist alone and in combination with a nonsteroidal anti-inflammatory agent in the treatment of experimental rhinovirus colds","volume":"65","author":"Sperber","year":"1989","journal-title":"Bull N Y Acad Med"},{"key":"2020051022381585600_ref24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1128\/AAC.26.1.31","article-title":"Intranasal interferon-\u03b12 for prevention of natural rhinovirus colds","volume":"26","author":"Farr","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051022381585600_ref25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jama.1967.03130190100014","article-title":"Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response","volume":"202","author":"Gwaltney","year":"1967","journal-title":"JAMA"},{"key":"2020051022381585600_ref26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2500\/105065895781874114","article-title":"Symptom expression in natural and experimental rhinovirus colds","volume":"9","author":"Rao","year":"1995","journal-title":"Am J Rhinol"},{"key":"2020051022381585600_ref27","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/JCM.35.11.2864-2868.1997","article-title":"Frequency and natural history of rhinovirus infections in adults during autumn","volume":"35","author":"Arruda","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2020051022381585600_ref28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/313661","article-title":"Nose blowing propels nasal fluid into the paranasal sinuses","volume":"30","author":"Gwaltney","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/186\/2\/147\/33197089\/186-2-147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/186\/2\/147\/33197089\/186-2-147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T02:38:46Z","timestamp":1589164726000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/186\/2\/147\/833594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2002,7,15]]},"published-print":{"date-parts":[[2002,7,15]]}},"URL":"https:\/\/doi.org\/10.1086\/341455","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published-other":{"date-parts":[[2002,7]]},"published":{"date-parts":[[2002,7]]}}}